Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monophosphoryl Lipid A Adjuvant and Modified Tree Pollen Allergens (MPL-Allergen)
- Target
- MPL-Allergen
- Molecular classification
- TLR4 Agonist, Adjuvant, Modified Allergen, Glycolipid, Protein
01
Overview
Monophosphoryl lipid A serves as a potent yet safe TLR4 agonist adjuvant that enhances adaptive immune responses when combined with modified tree pollen allergens. This approach shifts the immune response toward protective antibody production while minimizing allergic inflammation—a strategy validated both experimentally and clinically for allergy treatment and vaccine enhancement.
- Other names
- MPLModified Tree PollenMPL-allergen conjugateAllergen-TLR4 Agonist Vaccine
02
Mechanism of action
TLR4 agonism, induction of allergen-specific IgG antibodies, Th1 polarization
03
Biological functions
Immune modulationTLR4 signalingAntigen presentationAntibody productionTh1 polarizationB cell activation
04
Disease associations
Allergic rhinitisAllergic asthmaPollen allergy
05
Safety considerations
Injection site reactionsPotential for systemic inflammationRisk of allergic reactions to vaccine componentsAutoimmunity (theoretical)
06
Interacting drugs
Fendrix (Hepatitis B vaccine)
2 more in the full profile.
07
Biomarkers
Allergen-specific IgE levelsAllergen-specific IgG levels (IgG1, IgG4)TLR4 expressionCytokine profiles (IFN-γ, IL-4, IL-10)
Beyond the preview
Go deeper on Monophosphoryl Lipid A Adjuvant and Modified Tree Pollen Allergens (MPL-Allergen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Monophosphoryl Lipid A Adjuvant and Modified Tree Pollen Allergens (MPL-Allergen).